Hypertension

Annals of Internal Medicine

Volumn 161, Issue 11, 2014, Pages ITC1-ITC14

  Weir, Matthew R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE;

ANTIHYPERTENSIVE THERAPY; ARM CIRCUMFERENCE; ARTICLE; BLOOD PRESSURE CUFF; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; COMORBIDITY; DISEASE COURSE; ELEVATED BLOOD PRESSURE; HEALTH HAZARD; HOSPITALIZATION; HUMAN; HYPERTENSION; LABORATORY TEST; LIFESTYLE MODIFICATION; MASKED HYPERTENSION; MEDICAL HISTORY; MEDICAL SOCIETY; MEDICAL SPECIALIST; PATIENT CARE; PATIENT REFERRAL; PHYSICAL EXAMINATION; PREHYPERTENSION; PRESCRIPTION; SCREENING; SODIUM RESTRICTION; TREATMENT INDICATION; WHITE COAT HYPERTENSION;

EID: 84919482098     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-161-11-201412020-01006     Document Type: Article

References (50)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52. [PMID: 14656957]
2. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75. [PMID: 17159087]
3. U.S. Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2007;147:783-6. [PMID: 18056662]
4. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-20. [PMID: 24352797] doi:10.1001/jama.2013.284427
5. Allen NB, Siddique J, Wilkins JT, Shay C, Lewis CE, Goff DC, et al. Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. JAMA. 2014;311:490-7. [PMID: 24496536] doi:10.1001/jama.2013.285122
6. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al; Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685-97. [PMID: 16537662]
7. Batey DM, Kaufmann PG, Raczynski JM, Hollis JF, Murphy JK, Rosner B, et al. Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I). Ann Epidemiol. 2000;10:45-58. [PMID: 10658688]
8. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334:885-8. [PMID: 17449506]
9. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716. [PMID: 15699287]
10. Messerli FH. Osler's maneuver, pseudohypertension, and true hypertension in the elderly. Am J Med. 1986;80:906-10. [PMID: 2939716]
11. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368-74. [PMID: 16738273]
12. Angeli F, Verdecchia P, Gattobigio R, Sardone M, Reboldi G. White-coat hypertension in adults. Blood Press Monit. 2005;10:301-5. [PMID: 16496443]
13. Eguchi K, Hoshide S, Ishikawa J, Ishikawa S, Pickering TG, Gerin W, et al. Cardiovascular prognosis of sustained and white-coat hypertension in patients with type 2 diabetes mellitus. Blood Press Monit. 2008;13:15-20. [PMID: 18199919] doi:10.1097/MBP.0b013e3282f13f4a
14. Mallion JM, Clerson P, Bobrie G, Genes N, Vaisse B, Chatellier G. Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens. 2006;24:2365-70. [PMID: 17082717]
15. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291:1342-9. [PMID: 15026401]
16. Cicconetti P, Morelli S, De Serra C, Ciotti V, Chiarotti F, de Marle MG, et al. Left ventricular mass in dippers and nondippers with newly diagnosed hypertension. Angiology. 2003;54:661-9. [PMID: 14666954]
17. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401-6. [PMID: 12642361]
18. Fierro-Carrion GA, Ram CV. Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure [Editorial]. Am J Cardiol. 1997;80:775-6. [PMID: 9315588]
19. (KDIGO) Blood Pressure Work Group. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int [Suppl]. 2012;2:414.
20. Go AS, Bauman MA, Coleman King SM, Fonarow GC, Lawrence W, Williams KA, et al; American Heart Association. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014;63:878-85. [PMID: 24243703] doi:10.1161/HYP.0000000000000003
21. Committee on the Consequences of Sodium Reduction in Populations; Food and Nutrition Board; Board on Population Health and Public Health Practice; Institute of Medicine; Strom BL, Yaktine AL, Oria M, eds. Sodium intake in populations: assessment of evidence. Washington, DC: National Academy of Sciences; 2013:1-4. [PMID: 24851297]
22. O'Donnell M, Mente A, Rangarajan S, Mc-Queen MJ, Wang X, Liu L, et al; PURE Investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371:612-23. [PMID: 25119607] doi:10.1056/NEJMoa1311889
23. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81:341-54. [PMID: 15699220]
24. Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr. 1991;10:383-93. [PMID: 1910064]
25. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-24. [PMID: 9099655]
26. Bray GA, Vollmer WM, Sacks FM, Obarzanek E, Svetkey LP, Appel LJ; DASH Collaborative Research Group. A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. Am J Cardiol. 2004;94:222-7. [PMID: 15246908]
27. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279:839-46. [PMID: 9515998]
28. Fagrell B, De Faire U, Bondy S, Criqui M, Gaziano M, Gronbaek M, et al. The effects of light to moderate drinking on cardiovascular diseases. J Intern Med. 1999;246:331-40. [PMID: 10583704]
29. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension.2001;38:1112-7. [PMID: 11711507]
30. McGuire HL, Svetkey LP, Harsha DW, Elmer PJ, Appel LJ, Ard JD. Comprehensive lifestyle modification and blood pressure control: a review of the PREMIER trial. J Clin Hypertens (Greenwich). 2004;6:383-90. [PMID: 15249794]
31. Alexander CN, Schneider RH, Staggers F, Sheppard W, Clayborne BM, Rainforth M, et al. Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. Hypertension. 1996;28:228-37. [PMID: 8707387]
32. Taubert D, Roesen R, Schömig E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med. 2007;167:626-34. [PMID: 17420419]
33. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2000;283:1967-75. [PMID: 10789664]
34. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al; HYVET Study Group. N Engl J Med. 2008;358:1887-98. [PMID: 18378519] doi:10.1056/NEJMoa0801369
35. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-53. [PMID: 10639539]
36. Dahlöf B1, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al; ASCOT Investigators. Lancet. 2005;366:895-906.[PMID: 16154016]
37. Weir MR, Rosenberger C, Fink JC. Am J Hypertens. 2001;14:963-8. [PMID: 11587165]
38. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, et al; ACCOMPLISH Trial Investigators. N Engl J Med. 2008;359:2417-28. [PMID: 19052124] doi:10.1056/NEJMoa0806182
39. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, et al; ONTARGET Investigators. N Engl J Med. 2008;358:1547-59. [PMID: 18378520] doi:10.1056/NEJMoa0801317
40. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, et al; ALTITUDE Investigators. N Engl J Med. 2012;367:2204-13. [PMID: 23121378] doi:10.1056/NEJMoa1208799
41. Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, et al; VA NEPHRON-D Investigators. N Engl J Med. 2013;369:1892-903. [PMID: 24206457] doi:10.1056/NEJ Moa1303154
42. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Ann Intern Med. 2001;135:825-34. [PMID: 11694107]
43. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al; American Heart Association Professional Education Committee. Circulation. 2008;117:e510-26. [PMID: 18574054] doi:10.1161/CIRCULATIONAHA.108.189141
44. Moser M, Setaro JF. Clinical practice. N Engl J Med. 2006;355:385-92. [PMID: 16870917]
45. Pickering T. Am J Hypertens. 1996;9:1-11. [PMID: 8834700]
46. Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D; American Heart Association. Hypertension. 2008;52:1-9. [PMID: 18497371] doi:10.1161/HYPER-TENSIONA-HA.107.189011
47. Wilson MD, Johnson KA. Hypertension management in managed care: the role of home blood pressure monitoring. Blood Press Monit. 1997;2:201-206. [PMID: 10234118]
48. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al; British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139-85. [PMID: 14973512]
49. Townsend R. Hypertensive Crises. In Lankin PN, ed. The Intensive Care Unit Manual. Philadelphia: WB Saunders; 2000:602-14.
50. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens. 1995;13:915-24. [PMID: 8557970